Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "Polyomavirus allograft nephropathy"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation
Conditions: Acute Graft Rejection;   Chronic Allograft Nephropathy;   Polyomavirus-related Transplant Nephropathy
Intervention:
2 Completed Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy
Condition: Polyomavirus Infections
Interventions: Drug: CsA + MMF;   Drug: Tacr + MMF;   Drug: Tacr + MMF with conversion to Tacr + ERL

Indicates status has not been verified in more than two years